Adient has booked a Q2 (GAAP) net loss of US$149m and a loss of $1.59 per share for the second quarter of fiscal 2018/19.

Adjusted EPS was $0.31 and adjusted net income was off 83% to .

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Adjusted-EBIT and adjusted-EBITDA were $117m (down 53%) and $191m (-47%), respectively.

Revenue dipped 8% to $4,228m.

"Actions taken to improve Adient's operating and financial performance are taking hold, with greater improvement expected in the second half of FY19. In addition, the company's recent debt refinancing provides strong liquidity and capital structure flexibility to further enable our turnaround," said president and CEO Doug Del Grosso in a statement.

See Also:

During the second quarter, Adient reorganised some of its management structure, which resulted in a realignment of its Americas, EMEA and Asia reportable segments.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Seating sales fell 18% to $1,920m due to "significant production cuts in China," the supplier said.

Full fiscal year FY19 key financial expectations include revenue of $16.5bn to $16.7bn (no change to previous guidance) and equity income of $290m to $300m.